PARIS, May 06, 2024--CARMAT continues to build on its momentum in the EFICAS study and reiterates confidence in its 2024 outlook
PARIS, April 30, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), today announced the publication of the Company’s Universal registration document ("URD") for the year ended December 31, 2023.
PARIS, April 24, 2024--CARMAT announces its 2023 annual results and provides an update on its progress and prospects for 2024